Ultragenyx Pharmaceutical Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | 100.0% | -12,593.5% | -11,567.3% |
| FY2018 | 97.8% | -721.2% | -383.7% |
| FY2019 | — | -409.0% | -388.3% |
| FY2020 | — | -121.8% | -68.8% |
| FY2021 | — | -108.6% | -129.2% |
| FY2022 | — | -178.6% | -194.7% |
| FY2023 | — | -131.1% | -139.9% |
| FY2024 | — | -95.7% | -101.6% |
| FY2025 | — | -79.5% | -85.4% |